A Multi-center Retrospective Study of INO Treating B-ALL

Clinical trial NCT07238907 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT07238907
Sponsor: Ruijin Hospital
Status: ACTIVE_NOT_RECRUITING
Study type: OBSERVATIONAL

Acute Lymphoblastic Leukaemia Acute Lymphoblastic Leukaemias (ALL)Inotuzumab Ozogamicin Venetoclax

Start date: 2022-06-01
Primary completion: 2025-06-30
Enrollment: 102

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.